Influence of OATP1B1 and BRCP Genotype on Rosuvastatin PK, PD and Lipidomics in Hyperlipidemic Patients
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the pharmacokinetics, lipid lowering effect and
lipidomic profiles of 8-weeks rosuvastatin treatment by OATP1B1 genotype in hyperlipidemia
patients.